NJ State Employees Deferred Compensation Plan - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$354,280
-13.0%
17,0000.0%0.05%
-8.5%
Q2 2023$407,150
+27.3%
17,0000.0%0.06%
+20.4%
Q1 2023$319,940
+18.2%
17,0000.0%0.05%
+11.4%
Q4 2022$270,640
-2.6%
17,0000.0%0.04%
-8.3%
Q3 2022$278,000
+15.8%
17,0000.0%0.05%
+23.1%
Q2 2022$240,000
-41.7%
17,0000.0%0.04%
-30.4%
Q1 2022$412,000
+3.8%
17,0000.0%0.06%
+12.0%
Q4 2021$397,000
+40.8%
17,0000.0%0.05%
+31.6%
Q3 2021$282,000
-32.0%
17,0000.0%0.04%
-30.9%
Q2 2021$415,000
-5.5%
17,0000.0%0.06%
-11.3%
Q1 2021$439,000
-51.7%
17,0000.0%0.06%
-55.7%
Q4 2020$909,000
+29.7%
17,0000.0%0.14%
+11.1%
Q3 2020$701,000
-14.9%
17,0000.0%0.13%
-18.7%
Q2 2020$824,000
+14.8%
17,0000.0%0.16%
-5.5%
Q1 2020$718,000
-1.2%
17,0000.0%0.16%
+33.3%
Q4 2019$727,000
+18.8%
17,0000.0%0.12%
+9.8%
Q3 2019$612,000
+34.8%
17,0000.0%0.11%
+38.3%
Q2 2019$454,000
-19.5%
17,000
-19.0%
0.08%
-21.4%
Q1 2019$564,000
+65.9%
21,0000.0%0.10%
+45.1%
Q4 2018$340,000
-48.8%
21,000
-34.4%
0.07%
-37.2%
Q3 2018$664,000
+8.7%
32,000
-20.0%
0.11%
+3.7%
Q2 2018$611,00040,0000.11%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders